NCT01911039View on ClinicalTrials.gov

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

July 31, 2018

Conditions
Graft Versus Host DiseaseAllogeneic Hematopoietic Cell Transplant Recipient
Interventions
BIOLOGICAL

Regulatory T Cells

Trial Locations (1)

94305

Stanford University, School of Medicine, Palo Alto

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Laura Johnston

OTHER

NCT01911039 - Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD | Biotech Hunter | Biotech Hunter